LIVN LivaNova PLC
Price (delayed)
$47.09
Market cap
$2.56B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.31
Enterprise value
$2.59B
LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through
Highlights
The net income has soared by 83% YoY and by 48% from the previous quarter
LivaNova's EPS has surged by 83% YoY and by 47% QoQ
LIVN's debt is up by 9% year-on-year
Key stats
What are the main financial stats of LIVN
Market
Valuations
Earnings
Shares outstanding
54.3M
Market cap
$2.56B
Enterprise value
$2.59B
Price to book (P/B)
2.05
Price to sales (P/S)
2.11
EV/EBIT
N/A
EV/EBITDA
274.68
EV/Sales
2.14
Revenue
$1.21B
EBIT
-$46.96M
EBITDA
$9.44M
Free cash flow
$85.24M
Per share
Balance sheet
Liquidity
EPS
-$0.31
Free cash flow per share
$1.57
Book value per share
$22.95
Revenue per share
$22.3
TBVPS
$26.52
Total assets
$2.45B
Total liabilities
$1.21B
Debt
$668.69M
Equity
$1.24B
Working capital
$743.7M
Debt to equity
0.54
Current ratio
3.45
Quick ratio
2.75
Net debt/EBITDA
3.77
Margins
Efficiency
Dividend
EBITDA margin
0.8%
Gross margin
67.6%
Net margin
-1.4%
Operating margin
-2.2%
Return on assets
-0.7%
Return on equity
-1.3%
Return on invested capital
-4.2%
Return on capital employed
-2.2%
Return on sales
-3.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LIVN stock price
How has the LivaNova stock price performed over time
Intraday
0.06%
1 week
-6.55%
1 month
7.14%
1 year
-12.21%
YTD
-8.99%
QTD
-14.1%
Financial performance
How have LivaNova's revenue and profit performed over time
Revenue
$1.21B
Gross profit
$818.23M
Operating income
-$27.12M
Net income
-$16.59M
Gross margin
67.6%
Net margin
-1.4%
LIVN's net margin has soared by 84% year-on-year and by 48% since the previous quarter
The net income has soared by 83% YoY and by 48% from the previous quarter
LivaNova's operating margin has surged by 77% YoY and by 48% QoQ
The company's operating income has surged by 74% YoY and by 46% QoQ
Growth
What is LivaNova's growth rate over time
Valuation
What is LivaNova stock price valuation
P/E
N/A
P/B
2.05
P/S
2.11
EV/EBIT
N/A
EV/EBITDA
274.68
EV/Sales
2.14
LivaNova's EPS has surged by 83% YoY and by 47% QoQ
The price to book (P/B) is 21% lower than the 5-year quarterly average of 2.6 and 11% lower than the last 4 quarters average of 2.3
The price to sales (P/S) is 30% lower than the 5-year quarterly average of 3.0 and 16% lower than the last 4 quarters average of 2.5
LivaNova's revenue has increased by 12% YoY and by 2.1% from the previous quarter
Efficiency
How efficient is LivaNova business performance
The company's return on assets has surged by 84% YoY and by 46% QoQ
The return on equity has surged by 84% year-on-year and by 50% since the previous quarter
LivaNova's return on sales has decreased by 39% YoY but it has increased by 28% QoQ
The ROIC has grown by 30% from the previous quarter but it has contracted by 27% YoY
Dividends
What is LIVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LIVN.
Financial health
How did LivaNova financials performed over time
The company's total assets is 103% higher than its total liabilities
LivaNova's total liabilities has increased by 10% YoY but it has decreased by 2.2% QoQ
LivaNova's quick ratio has increased by 10% YoY and by 9% QoQ
LIVN's debt is 46% smaller than its equity
LIVN's debt is up by 9% year-on-year
LIVN's debt to equity is up by 8% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.